Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak
Research
[키워드] Adults
antiviral drug
antiviral therapy
biochemical
Blood
caused
children
children with COVID-19
clinical manifestations
Cohort
cohort study
collected
Computed tomography
Contingency table
coronavirus
COVID-19
COVID-19 cohort
COVID-19 outbreak
D-dimer
defined
diagnosed
drug usage
enrolled
evaluated
Fever
GGO
ground-glass opacity
hospital
Immunotherapy
incidence of COVID-19
individual
Infection
Inflammatory indicators
intensive care
Kolmogorov-Smirnov test
Laboratory
Lopinavir-ritonavir
Mann-Whitney U test
median
median age
métapneumovirus
need for oxygen
Older
organ
other respiratory virus
outcome
Panic
parainfluenza
pathogen
Pharyngeal swab
Pneumonia
positive PCR result
proportion
respiratory syncytial virus
Result
retrospective
rhinovirus
ribavirin
secondary bacterial infection
Severe acute respiratory syndrome
Severe case
severity of COVID-19
significantly lower
statistical difference
Support
Symptom
symptomatic
t-test
tissue damage
Treatment
Viral pneumonia
virus
with COVID-19
[DOI] 10.1186/s40779-021-00306-7 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s40779-021-00306-7 PMC 바로가기 [Article Type] Research